September 9, 2016 06:07 PM EDT
R&D

Gene edit­ing star CRISPR Ther­a­peu­tics files for $90M IPO

John Carroll

Editor & Founder

In one of the most high­ly an­tic­i­pat­ed biotech IPOs of the year, CRISPR Ther­a­peu­tics has filed its S-1 out­lin­ing its plans to raise

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump el­e­vates dis­proven link be­tween vac­cines and autism, say­ing ‘some­thing is go­ing on’

Po­lice ar­rest per­son of in­ter­est in con­nec­tion with killing of Unit­ed­Health­care CEO

Ex­clu­sive: Vi­jay Pande hands a16z biotech lead­er­ship to Vi­nee­ta Agar­wala, moves to AI role

ADC sci­en­tist who paved the way for Dai­ichi’s En­her­tu dies

GSK re­ports Blenrep over­all sur­vival da­ta in mul­ti­ple myelo­ma as it plots mar­ket reen­try

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times